US2011136732A1PendingUtilityA1
Infant nutritional compositions for preventing obesity
Est. expiryDec 23, 2025(expired)· nominal 20-yr term from priority
A61P 9/10A61P 9/00A61P 3/10A61P 3/06A61P 25/00A61P 3/04A61P 3/02A61K 31/198A23V 2002/00A61K 31/20A61K 35/20A61K 31/7016A61K 31/688A61K 31/185A61K 31/201A61K 31/575A61K 31/702A23L 33/12A61K 31/14A61K 38/1709A61K 31/202A23L 33/125A23L 33/40
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for preventing obesity later in life by administering a certain nutritional composition to an infant with the age between 0 and 36 months. The composition comprises linoleic acid and alpha-linolenic acid.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . The method of claim 15 , wherein the composition comprises 3-50 wt. % MCFA based on total fatty acids.
3 . The method of claim 15 , wherein the weight ratio of LN to ALA is between 2 and 5.
4 . The method of claim 15 , wherein the composition further comprises at least 0.5 wt. % of at least one soluble, non-digestible oligosaccharide based on dry weight of the composition.
5 . The method of claim 9 , wherein the at least one soluble, non-digestible oligosaccharide is selected from the group consisting of fructo-oligosaccharides, galacto-oligosaccharides, gluco-oligosaccharides, arabino-oligosaccharides, mannan-oligosaccharides, xylo-oligosaccharides, fuco-oligosaccharides, arabinogalacto-oligosaccharides, glucomanno-oligosaccharides, galactomanno-oligosaccharides, sialic acid-comprising oligosaccharides and uronic acid oligosaccharides.
6 . The method of claim 15 , wherein the composition comprises galacto-oligosaccharides.
7 . The method of claim 6 , wherein the composition further comprises fructo-oligosaccharides.
8 . The method of claim 15 , wherein said feeding prevents the development of obesity later-in-life and/or prevents the development of obesity when said infant has reached an age above 36 months.
9 . The method of claim 15 , wherein the composition further comprises:
(a) 0.5 to 20 wt. % phospholipids based on weight of total lipid in the composition; (b) 0.5 to 20 wt. % sphingolipids based on weight of total lipid in the composition; (c) 0.005 to 10 wt. % cholesterol based on weight of total in the composition; and/or (d) 0.035 to 1 wt. % choline based on dry weight of the composition; and (e) 0.001 to 0.1 wt. % uridine based on dry weight of the composition.
10 . The method of claim 15 , wherein
(a) the lipid component provides 35 to 55% of the total calories of said composition, (b) the protein component provides 5 to 15% of the total calories of said composition, and (c) the digestible carbohydrate component provides 30 to 60% of the total calories of said composition.
11 . The method of claim 15 , wherein the composition provides 60-90 kcal/100 ml.
12 . The method of claim 15 , wherein said feeding prevents the development of obesity at an age above 12 years.
13 . The method of claim 15 , wherein said feeding is of an infant aged below 12 months.
14 . The method of claim 15 , wherein the composition comprises at least 0.3 wt. % calcium based on dry weight of the composition.
15 . A method to prevent obesity in an a non-obese human infant, comprising feeding a human infant younger than 36 month of age with a nutritional composition that comprises a lipid component, a protein component and a digestible carbohydrate component,
wherein the lipid component comprises: linoleic acid (LA) and a-linolenic acid (ALA) in a weight ratio of LA to ALA of between 2 and 7; (ii) less than 15 wt. % LA based on weight of total fatty acids in the composition; and (iii) at least 1 wt. % ALA based on weight of total fatty acids in the composition,
which composition further comprises at least one of:
(a) 3-50 wt. % MCFA based on total fatty acids
(b) n-6 long chain polyunsaturated fatty acids (LC-PUFA) and n-3 LC-PUFA in a weight ratio of below 1.5, wherein the content of the n-6 LC-PUFA and n-3 LC-PUFA are:
(1) from 0.02 to 0.8 wt. % n-6 LC-PUFA based on total fatty acids, and
(2) at least 0.2 wt. % n-3 LC-PUFA based on total fatty acids.Join the waitlist — get patent alerts
Track US2011136732A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.